ProPhase Labs, Inc. Treasury Stock, Common, Value
ProPhase Labs, Inc. (PRPH) had Treasury Stock, Common, Value of $49.64 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-08-19
- 2026-06-30: Treasury Stock, Common, Value $49.64M.
- 2026-03-31: Treasury Stock, Common, Value $49.64M.
- 2025-12-31: Treasury Stock, Common, Value $49.64M.
- 2025-09-30: Treasury Stock, Common, Value $49.64M.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $49.64M 10-Q · filed 2026-08-19 |
| 2026-03-31 | $49.64M 10-Q/A · filed 2026-07-09 |
| 2025-12-31 | $49.64M 10-Q · filed 2026-08-19 |
| 2025-09-30 | $49.64M 10-Q · filed 2025-11-19 |
| 2025-06-30 | $49.64M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $49.64M 10-Q · filed 2025-05-20 |
| 2024-12-31 | $64.00M 10-K · filed 2026-06-01 |
| 2024-09-30 | $64.00M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $64.00M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $64.00M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $64.00M 10-K · filed 2025-04-01 |
| 2023-09-30 | $64.00M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $64.00M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $63.95M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $58.03M 10-K · filed 2024-03-29 |
| 2021-12-31 | $48.41M 10-K · filed 2023-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |